Synergistic lipid-lowering effects of Zingiber mioga and Hippophae rhamnoides extracts

被引:5
|
作者
Park, So-Hyun [1 ,2 ]
Lee, Da-Hye [1 ,2 ]
Choi, Hyun-Il [2 ]
Ahn, Jiyun [1 ,2 ]
Jang, Young-Jin [2 ]
Ha, Tae-Youl [1 ,2 ]
Jung, Chang Hwa [1 ,2 ]
机构
[1] Univ Sci & Technol, Dept Food Biotechnol, Wanju Gun 55365, Jeollabuk Do, South Korea
[2] Korea Food Res Inst, Res Grp Nat Mat & Metab, 245 Nongsaengmyeong Ro, Wanju Gun 55365, Jeollabuk Do, South Korea
关键词
synergistic effect; lipid accumulation; anti-obesity; Zingiber mioga; Hippophae rhamnoides; TRANSCRIPTIONAL REGULATION; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; PUNGENT PRINCIPLE; ADIPOGENESIS; OBESITY; CELLS; MYOGA; PATHOGENESIS; ANTIOXIDANT;
D O I
10.3892/etm.2020.8913
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The effects of a mixture of Hippophae rhamnoides (HR) and Zingiber mioga (ZM) extract (ZH) on intracellular lipid accumulation were investigated in vitro and the anti-obesity effects of ZH evaluated in mice with high-fat diet-induced obesity. The results revealed that ZH inhibited lipid accumulation in 3T3-L1 adipocytes and Huh-7 cells by suppressing adipogenic and lipogenic gene and protein expression. To evaluate the anti-obesity effects of ZH, mice fed a high-fat diet were orally administered low and high doses of ZH (low, ZM 400 mg/kg + HR 100 mg/kg; high, ZM 800 mg/kg + HR 200 mg/kg) for 9 weeks. ZH significantly reduced body weight gain and adipose tissue accumulation with no reduction in food intake when compared to control treatment. Furthermore, ZH reduced hepatic triglyceride and total cholesterol levels, as well as adipose cell size, in the liver and epididymal fat pads, respectively, through inhibition of adipogenesis and lipogenesis-related gene expression. These results suggested that ZH inhibits lipid accumulation, thereby indicating its potential for use as a new therapeutic strategy for obesity.
引用
收藏
页码:2270 / 2278
页数:9
相关论文
共 50 条
  • [31] SOAT2, a new target of intestinal lipid-lowering drugs, mediates lipid uptake inhibition and lipid-lowering effects
    Liang, Jingjia
    Shao, Wentao
    Gu, Aihua
    CHINESE SCIENCE BULLETIN-CHINESE, 2023, 68 (16): : 2124 - 2132
  • [32] Effects of Lipid-Lowering Drugs on Vancomycin Susceptibility of Mycobacteria
    Rens, Celine
    Laval, Francoise
    Daffe, Mamadou
    Denis, Olivier
    Frita, Rosangela
    Baulard, Alain
    Wattiez, Ruddy
    Lefevre, Philippe
    Fontaine, Veronique
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (10) : 6193 - 6199
  • [33] CUTANEOUS SIDE-EFFECTS OF LIPID-LOWERING AGENTS
    PROKSCH, E
    HAUTARZT, 1995, 46 (02): : 76 - 80
  • [34] Statins show beneficial effects beyond lipid-lowering
    不详
    SOUTH AFRICAN MEDICAL JOURNAL, 1997, 87 : C123 - C123
  • [35] Lipid-lowering effects of Danhong injection on hyperlipidemia rats
    Chen, Juan
    Deng, Jun
    Zhang, Yuyan
    Yang, Jiehong
    He, Yu
    Fu, Wei
    Xing, Panke
    Wan, Hai Tong
    JOURNAL OF ETHNOPHARMACOLOGY, 2014, 154 (02) : 437 - 442
  • [36] Lipid-lowering drugs: Are adverse effects predictable and reversible?
    Muscari, A
    Puddu, GM
    Puddu, P
    CARDIOLOGY, 2002, 97 (03) : 115 - 121
  • [37] Effects of evolving lipid-lowering drugs on carbohydrate metabolism
    Tsimihodimos, V.
    Elisaf, M.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 137 : 1 - 9
  • [38] Effects of lipid-lowering therapy on total and coronary mortality
    Holme, I
    CURRENT OPINION IN LIPIDOLOGY, 1995, 6 (06) : 374 - 378
  • [39] EFFECTS OF LIPID-LOWERING THERAPY ON PLATELET ACTIVATION INVIVO
    FORCE, T
    FREEMAN, M
    KEILSON, L
    MILANI, R
    CURTIS, K
    LEAF, A
    WEBER, P
    CIRCULATION, 1992, 86 (04) : 868 - 868
  • [40] Atorvastatin: beyond lipid-lowering effects in the diabetic population
    Ramos, Julie
    Khan, Qamar A.
    Thoenes, Martin
    Khan, Bobby V.
    FUTURE CARDIOLOGY, 2006, 2 (05) : 527 - 533